Deflazacort
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11921 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 59 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | limb-girdle muscular dystrophy | KG + DL |
| 2 | nebulin-related early-onset distal myopathy | KG + DL |
| 3 | obsolete autosomal dominant limb-girdle muscular dystrophy type 1C | KG + DL |
| 4 | distal myopathy, Welander type | KG + DL |
| 5 | X-linked myopathy with postural muscle atrophy | KG + DL |
| 6 | distal myopathy with anterior tibial onset | KG + DL |
| 7 | MYH7-related skeletal myopathy | KG + DL |
| 8 | myofibrillar myopathy | KG + DL |
| 9 | disorder of O-mannosylglycan synthesis | KG + DL |
| 10 | X-linked Emery-Dreifuss muscular dystrophy | KG + DL |
| 11 | muscular channelopathy | KG + DL |
| 12 | qualitative or quantitative defects of merosin | KG + DL |
| 13 | congenital muscular alpha-dystroglycanopathy with brain and eye anomalies | KG + DL |
| 14 | qualitative or quantitative defects of fukutin | KG + DL |
| 15 | muscular dystrophy-white matter spongiosis syndrome | KG + DL |
| 16 | Cyprus facial-neuromusculoskeletal syndrome | KG + DL |
| 17 | Tel Hashomer camptodactyly syndrome | KG + DL |
| 18 | MYH7-related late-onset scapuloperoneal muscular dystrophy | KG + DL |
| 19 | atrophic muscular disease | KG + DL |
| 20 | muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a | KG + DL |
| 21 | X-linked scapuloperoneal muscular dystrophy | KG + DL |
| 22 | Bethlem myopathy | KG + DL |
| 23 | qualitative or quantitative defects of desmin | KG + DL |
| 24 | acquired skeletal muscle disease | KG + DL |
| 25 | oculopharyngeal muscular dystrophy | KG + DL |
| 26 | qualitative or quantitative defects of FKRP | KG + DL |
| 27 | facioscapulohumeral muscular dystrophy | KG + DL |
| 28 | qualitative or quantitative defects of selenoprotein N1 | KG + DL |
| 29 | Duchenne and Becker muscular dystrophy | KG + DL |
| 30 | akinetopsia | KG + DL |
| 31 | myopathy, distal, with rimmed vacuoles | KG + DL |
| 32 | qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase | KG + DL |
| 33 | Wieacker-Wolff syndrome (spectrum) | KG + DL |
| 34 | Miyoshi muscular dystrophy | KG + DL |
| 35 | adult-onset distal myopathy due to VCP mutation | KG + DL |
| 36 | autosomal dominant limb-girdle muscular dystrophy type 1E (DES) | KG + DL |
| 37 | autosomal recessive Emery-Dreifuss muscular dystrophy | KG + DL |
| 38 | autosomal dominant Emery-Dreifuss muscular dystrophy | KG + DL |
| 39 | myotonic cataract | KG + DL |
| 40 | oculogastrointestinal muscular dystrophy | KG + DL |
| 41 | distal myopathy | KG + DL |
| 42 | intellectual disability-hyperkinetic movement-truncal ataxia syndrome | KG + DL |
| 43 | Emery-Dreifuss muscular dystrophy | KG + DL |
| 44 | distal myopathy with posterior leg and anterior hand involvement | KG + DL |
| 45 | qualitative or quantitative defects of dysferlin | KG + DL |
| 46 | Miyoshi myopathy | KG + DL |
| 47 | limb-girdle muscular dystrophy due to POMK deficiency | KG + DL |
| 48 | myopathy, distal | KG + DL |
| 49 | oculopharyngodistal myopathy | KG + DL |
| 50 | autosomal dominant distal myopathy | KG + DL |
(Showing top 50 of 59 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.